| HOME >> BIOLOGY >> TECHNOLOGY |
FREMONT, Calif., March 3 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced the promotion of two members of the company's management team. Kumar Kastury, Ph.D., director of assay development, has been promoted to vice president of assay development and John McEntee, director of engineering, has been promoted to associate vice president of engineering. The company also announced that Terry W. Osborn, Ph.D., MBA, chief operating officer, is leaving WaferGen to pursue other interests.
"John and Kumar have both made key contributions to WaferGen since joining the company. Considering their previous work and extensive industry expertise, both of these promotions are well-deserved," said Alnoor Shivji, chairman and chief executive officer. "At the same time, we would like to acknowledge the valuable service that Terry has provided WaferGen during his tenure with the company. We wish him the very best in his future pursuits."
As vice president of assay development, Dr. Kastury will serve as a key corporate interface with WaferGen's recently established Malaysian subsidiary. He will be responsible for fostering and managing the subsidiary's collaborative relationships while also overseeing the group's SmartChip(TM) Real-Time PCR System assay development activities, including the development of therapeutically-relevant assays and biomarkers. In his new role as associate vice president of engineering, Mr. McEntee will continue to be responsible for the engineering of the SmartChip Real-Time PCR System, while also coordinating and managing the activities of the company's manufacturing partners in Malaysia.
With extensive experience in the areas of gene expression and cell
biology, Dr. Kastury has served as WaferGen's director of research and
development since 2007. He joined WaferGen from Gen-
'/>"/>
| SOURCE WaferGen Biosystems Inc. Copyright©2008 PR Newswire. All rights reserved |